Meningococcal group C disease in Greece during 1993-2006: The impact of an unofficial single-dose vaccination scheme adopted by most paediatricians

24Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The aim of this study was to evaluate the impact of the meningococcal C conjugate vaccine on the epidemiology of meningococcal C disease in Greece. Data from the National Reference Laboratory for Meningococcal Disease and a questionnaire distributed to Greek paediatricians were assessed. Since the introduction of the vaccine in 2001, 72% of Greek paediatricians have administered it as one single dose to patients aged ≥12 months. This vaccination scheme has probably contributed to a dramatic decrease in the number of meningococcal C infections, which reached zero in 2004. © 2007 European Society of Clinical Microbiology and Infectious Diseases.

Cite

CITATION STYLE

APA

Kafetzis, D. A., Stamboulidis, K. N., Tzanakaki, G., Kremastinou, J. K., Skevaki, C. L., Konstantopoulos, A., & Tsolia, M. (2007). Meningococcal group C disease in Greece during 1993-2006: The impact of an unofficial single-dose vaccination scheme adopted by most paediatricians. Clinical Microbiology and Infection, 13(5), 550–552. https://doi.org/10.1111/j.1469-0691.2007.01704.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free